CNSY

0.630110.29%
RH

Russ Havranek

Executive Vice President of Commercial and Corporate Strategy

Mr. Russ Havranek, MS, MBA, serves as Executive Vice President of Commercial and Corporate Strategy at Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) since September 2025 and was its Vice President of Corporate Strategy & New Product Planning until September 2025. Mr. Havranek served as a Vice President of Marketing, Portfolio Management and Investor Relations at Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) Mr. Havranek served as Vice President of Global Marketing and Business Development at Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.) (formerly, Cytori Therapeutics, Inc). Mr. Havranek served as Vice President of Global Marketing at Cytori Therapeutics, Inc. since August 24, 2016. He joined Cytori in 2014. Mr. Havranek has extensive marketing, general management and product development experience with major life science companies including CareFusion Corporation, Volcano Corporation, Guidant Corporation and Johnson & Johnson. Mr. Havranek received a M.B.A. in Marketing from the University of California, Berkeley, a M.S. in Bioengineering from Clemson University and a B.S. in Biomedical Engineering from Northwestern University.

Positions